Teledyne’s high-speed, high-resolution Contact Image Sensors are now available in color
WATERLOO, Canada, July 09, 2024 (GLOBE NEWSWIRE) — Teledyne DALSA is pleased to announce that its AxCIS™ family of high-speed […]
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
MALVERN, Pa., July 09, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), […]
Apollo Commercial Real Estate Finance, Inc. Announces Dates for Second Quarter 2024 Earnings Release and Conference Call
NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today […]
SHARC Energy Secures $2 Million Debenture from Sole Subscriber
VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC […]
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
— Dr. Laufer is an immunologist advancing the scientific understanding and treatment of autoimmune diseases — BERKELEY, Calif., July 09, […]
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical […]
Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease
– Abiprubart Phase 2b clinical trial in Sjögren’s Disease to evaluate treatment response across biweekly and monthly subcutaneous administrations – – […]
Clene Announces 1-for-20 Reverse Stock Split
SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]
TSX News -
FirstService to Announce Second Quarter Results on July 25, 2024
TORONTO, July 09, 2024 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release […]
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan
GAITHERSBURG, Md., July 09, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today highlights several recent advancements in improving […]
